Key Allegation Every Ozempic lawsuit centers on one claim: Novo Nordisk failed to warn patients and doctors about the serious risk of gastroparesis and vision loss
This will help our partner providers understand your unique health profile and determine the safest, most effective treatment plan for you
Outlook and future perspectives It is 30 years since the first demonstration of the glucose-lowering effects of the gut hormone GLP-1 in people with diabetes [9]
GLP-1 Weight Loss Without Exercise: What to Expect GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda) can produce clinically significant weight loss without structured exercise, though outcomes vary between individuals
CGM Integration connects your continuous glucose monitor data to the Oura App, so your glucose trends appear alongside your sleep, HRV, and activity data
Brand-Name Pricing Without insurance coverage, brand-name semaglutide (Wegovy) and tirzepatide (Zepbound) carry list prices exceeding $1,000 per month